Fondazione del Piemonte per l'Oncologia (IRCCS)

Candiolo 10060

0 studies enrolling now · 2 studies all time

What they study most

HER2-amplified Biliary Tract Cancers, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV

Studies at this site

• A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early